Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-052405
Filing Date
2018-10-03
Accepted
2018-10-03 19:01:15
Documents
1
Period of Report
2018-02-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv503773_4.html 4  
1 OWNERSHIP DOCUMENT tv503773_4.xml 4 6688
  Complete submission text file 0001144204-18-052405.txt   8124
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 840 PARK AVE HOBOKEN NJ 07030
Business Address
Durso Jerome Benedict (Reporting) CIK: 0001698665 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 181106562